Insights On Trial Design

31. Flexible By Design: Support For Early-Phase Oncology Trial 7/8/2026

    Shifting cohorts, doses, and protocols challenge early-phase oncology trials. Learn how adaptable technology keeps studies on track.

32. Bring Your Own Device (BYOD) Clinical Trials 4/8/2025

    Bring Your Own Device (BYOD) is revolutionizing clinical trials by enabling participants and researchers to use their own smartphones, tablets, or computers to collect and manage data.

33. Five Preventable Clinical Design Pitfalls And How To Avoid Them 7/21/2026

    While late-stage trial attrition is often attributed to inadequate safety or efficacy, the true failure may be insufficient upstream planning and/or misalignment between clinical and commercial goals.

34. Automation Testing In RTSM Software: What Is It And What's The Impact 2/25/2026

    Move beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.

35. Challenges That Derail Bladder Cancer Trials And How To Anticipate Them Earlier 3/5/2026

    From the rapid evolution of standard-of-care benchmarks to the logistical strain of procedure-heavy urology workflows, the path to a successful endpoint is filled with operational friction.

36. Control And Transparency: Solving Sponsors' Key Challenges In Study Launch 9/10/2024

    Learn how SaaS technology can revolutionize clinical trial launches by improving transparency, increasing control, and streamlining efficiency.

37. Why Clinical Trial Demographics Don't Match Real-World Populations 12/4/2025

    Representative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.

38. The Triple Effect Of Community-Based Clinical Trials 6/24/2026

    Taking trials into local communities improves access, boosts enrollment, reduces dropouts, and yields more representative data, speeding timelines and strengthening study quality.

39. Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions 5/8/2026

    Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.

40. The Role Of Oncology Biomarkers In Personalizing Hematology Treatment Plans 6/18/2026

    Oncology biomarkers guide personalized treatment and help track disease changes. Learn more about how advancements like liquid biopsies improve precision care.